TSFV portfolio company BenchSci announces additional investment from Gradient Ventures, Google’s AI-focused venture fund, to meet growing demand from pharmaceutical companies for its biomedical AI technology, which empowers scientists to run more successful experiments to accelerate drug discovery. It brings BenchSci’s total funding to $27.2 million.
Great to see that Gradient Ventures is doubling down. BenchSci has been a rocket ship since TSFV invested 3 years ago. Let’s keep rocking!
